Fungal infectious disease
MONDO:0002041An infection caused by a fungus.
Also known as: Fungi caused disease or disorder, Fungi disease or disorder, Fungi infection, Fungi infectious disease, mycosis, fungal infection, infection, fungal, infections, Fungi
293 clinical trials for this condition and its sub-types, 38 tagged with Fungal infectious disease itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Fungal infectious disease
-
Opportunistic mycosis 0 trials · 147 incl. sub-types
12 sub-types
- Candidiasis 18 trials · 57 incl. sub-types Sub-types →
- Aspergillosis 19 trials · 55 incl. sub-types Sub-types →
- Opportunistic systemic mycosis 0 trials · 23 incl. sub-types Sub-types →
- Zygomycosis 19 trials Sub-types →
- Pneumocystosis 19 trials
- Cryptococcosis 5 trials · 10 incl. sub-types Sub-types →
- Fusariosis 4 trials
- Hyalohyphomycosis 1 trial
- Geotrichosis 0 trials
- Maple bark strippers' lung 0 trials
- Microsporidiosis 0 trials Sub-types →
- Phaeohyphomycosis 0 trials
-
Cutaneous mycosis 1 trial · 118 incl. sub-types
5 sub-types
- Tinea infection 1 trial · 116 incl. sub-types Sub-types →
- Superficial mycosis 0 trials · 88 incl. sub-types Sub-types →
- Dermatomycosis 1 trial Sub-types →
- Cutaneous basidiobolomycosis 0 trials
- Subcutaneous mycosis 0 trials Sub-types →
-
Fungal lung infectious disease 6 trials · 57 incl. sub-types
5 sub-types
- Pulmonary aspergilloma 11 trials · 38 incl. sub-types Sub-types →
- Pneumocystosis 19 trials
- Adiaspiromycosis 0 trials
- Cork-handlers' disease 0 trials
- Maple bark strippers' lung 0 trials
-
Systemic mycosis 27 trials · 54 incl. sub-types
3 sub-types
- Opportunistic systemic mycosis 0 trials · 23 incl. sub-types Sub-types →
- Primary systemic mycosis 0 trials · 9 incl. sub-types Sub-types →
- Disseminated sporotrichosis 0 trials
-
Pneumocystis infectious disease 4 trials · 19 incl. sub-types
1 sub-type
- Pneumocystosis 19 trials
-
Fungal meningitis 3 trials · 10 incl. sub-types
2 sub-types
- Cryptococcal meningitis 7 trials
- Histoplasmosis meningitis 0 trials
-
Fungal infection of eye 0 trials · 7 incl. sub-types
2 sub-types
- Fungal keratitis 6 trials
- Histoplasmosis retinitis 1 trial
-
Scedosporiosis 2 trials
-
Sporotrichosis 1 trial
1 sub-type
- Disseminated sporotrichosis 0 trials
-
Alternariosis 0 trials
1 sub-type
- Phaeohyphomycosis 0 trials
-
Emergomycosis 0 trials
-
Fungal discitis 0 trials
-
Fungal esophagitis 0 trials
1 sub-type
- Esophageal candidiasis 0 trials
-
Fungal gastritis 0 trials
-
Fungal myositis 0 trials
-
Invasive scopulariopsis infection 0 trials
-
Mycotic endocarditis 0 trials
-
Mycotoxicosis 0 trials
1 sub-type
- Ergotism 0 trials
Most studied deeper sub-types
-
Three-Drug antifungal cocktails put to the test against stubborn skin fungus
Disease control CompletedDermatophytosis, a common fungal skin infection, often becomes chronic and resists standard treatment. Researchers are comparing three oral antifungal combinations: terbinafine plus fluconazole, terbinafine plus itraconazole, and terbinafine plus voriconazole. The trial enrolls 1…
Sponsor: Chittagong Medical College • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Biomarker test could cut unnecessary antifungal use in ICU
Disease control CompletedThis study tested whether using special fungal markers (biomarkers) could help doctors safely stop antifungal drugs earlier in ICU patients. The goal was to reduce the length of treatment and avoid unnecessary side effects. The study included 110 critically ill adults who needed …
Sponsor: University Hospital, Lille • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New gel shows promise for ugly toenail fungus
Disease control CompletedThis study tested a special gel, CGB-400, on 15 adults with toenail fungus. The goal was to see if the gel could clear the fungus and make the nails look better. Participants applied the gel for 12 weeks, with follow-up visits to check progress.
Sponsor: CAGE Bio Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New antifungal drug APX001 passes first safety check in humans
Disease control CompletedThis early-stage trial tested the safety and tolerability of a new antifungal drug called APX001 in 200 healthy volunteers. Participants received either single or multiple doses of the drug or a placebo. The study focused on side effects and how the drug moves through the body, n…
Phase 1 • Sponsor: Basilea Pharmaceutica • Aim: Disease control
Last updated Jun 26, 2026 15:43 UTC
-
Could a mouthwash replace a tube down your throat to diagnose pneumonia?
Diagnosis CompletedThis study tests whether a simple salt-water mouth rinse can detect pneumocystis, a lung infection that can be life-threatening in people with weak immune systems. Current diagnosis requires coughing up sputum or a tube inserted into the lungs, which can be uncomfortable. Researc…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Diagnosis
Last updated Sep 18, 2026 00:00 UTC
-
New drug could shield transplant patients from deadly fungal infections
Prevention CompletedThis study tested a new medicine called rezafungin to see if it can prevent serious fungal infections in adults getting a bone marrow transplant. About 600 participants received either rezafungin or the standard treatment. The goal was to see if rezafungin helps more people stay …
Phase 3 • Sponsor: Mundipharma Research Limited • Aim: Prevention
Last updated Jun 27, 2026 12:07 UTC
-
Scientists probe Drug-Induced sunburn reactions
Knowledge-focused CompletedThis study looks at why some medications, like the antifungal voriconazole, can cause extreme sensitivity to sunlight, leading to severe sunburn-like reactions. Researchers will measure gene activity in skin samples from 62 participants, including healthy volunteers and patients …
Phase 1 • Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
Hidden fungal threat in COVID-19 ICU patients revealed
Knowledge-focused CompletedThis study monitored 219 adults with severe COVID-19 who needed a ventilator for at least 72 hours. Researchers checked for serious fungal infections, especially aspergillosis, using standard diagnostic methods. The goal was to learn how common these infections are and what puts …
Sponsor: University of Alabama at Birmingham • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC
-
New antifungal drug APX001 gets first human safety check
Knowledge-focused CompletedThis Phase 1 trial tested the safety and tolerability of a new antifungal drug called APX001 in 46 healthy volunteers. Researchers gave single and multiple doses, both orally and intravenously, to see how the body handles the drug and whether food affects it. The study also looke…
Phase 1 • Sponsor: Basilea Pharmaceutica • Aim: Knowledge-focused
Last updated Jun 26, 2026 15:46 UTC